SI-BONE makes surgical and medical devices sold to surgeons and other healthcare providers. SIBN reports earnings on Mon, Nov 2, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 14 | Truist Securities | Target raised | Buy | |
| Aug 4 | UBS | Target raised | Buy | |
| Aug 4 | Truist Securities | Target raised | Buy | |
| Aug 4 | TD Cowen | Maintained | Buy | |
| Jul 28 | UBS | Initiated | Buy |
Seasonality
How SIBN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
Whale Options Flow
90DNo whale options trades in SIBN in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SIBN is in one of them and how their past SIBN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SIBN in an article yet. Here's the latest on the wider market.
About SI-BONE
SI-BONE makes surgical and medical devices that are used in procedures performed by surgeons. Its customers include physicians and other healthcare providers who use its products with patients. The company is headquartered in San Jose, California.
- Headquarters
- San Jose, CA
- Founded
- 2008
- Website
- si-bone.com ↗